coherent rega 9000 manual

File Name:coherent rega 9000 manual.pdf
Size:1618 KB
Type:PDF, ePub, eBook, fb2, mobi, txt, doc, rtf, djvu
Category:Book
Uploaded30 May 2019, 18:36 PM
InterfaceEnglish
Rating4.6/5 from 638 votes
StatusAVAILABLE
Last checked19 Minutes ago!

coherent rega 9000 manual

Visit our Contact Page to connect with any of our global sites.Besuchen Sie unsere Kontaktseite, um direkt Kontakt mit einem unserer weltweiten Standorte aufzunehmen.Visitez notre page de contacts et mettez-vous en relation avec l’un de nos sites mondiaux. Visit our Contact Page to connect with any of our global sites.Visit our Contact Page to connect with any of our global sites. What is the maximum pulse energy. The system is a Coherent regenerative The beam diameter Third Harmonic Product Third Harmonic Generator Manual -Harmonic Generator manual Ti:Sapphire Laser. E-mail us for a custom quote Third Harmonic Generator Manual -Harmonic Generator manual Source Cortes Cr:Forsterite. Regenerative Amplifier Infrared Cross-correlator Rincon Femtosecond Autocorrelator Cr:Forsterite laser OAFP optical attenuator Pearls femtosecond fiber laser Femtosecond Second Harmonic Generator Spectrometer ASP-100M Spectrometer ASP-150C Spectrometer ASP-IR Tamarack and Buccaneer. Teahupoo femtosecond Ti:Sapphire regenerative amplifier Femtosecond Ti:Sapphire laser Trestles Finesse Wedge Ti:Sapphire multipass amplifier. Utilizing chirped pulse amplification, the RegA amplifies seed pulses from the Mira or Vitara depending on the final performance requirements. Stretching and compression are accomplished within the RegA package. The standard seed laser for this RegA is a femtosecond Mira. Although it possesses the same fundamental design as the RegA 9000, it incorporates an external stretcher and compressor. The amplifier is seeded by a Vitara-T. Pulse stretching and compression are accomplished within the RegA package. The RegA may be seeded with pulses from a femtosecond Mira and Vitara. Although it possesses the same fundamental design as the RegA 9000, it incorporates an external stretcher and compressor. The amplifier must be seeded by high bandwidth pulses from a Vitara. Visit our Contact Page to connect with any of our global sites.

Besuchen Sie unsere Kontaktseite, um direkt Kontakt mit einem unserer weltweiten Standorte aufzunehmen.Visitez notre page de contacts et mettez-vous en relation avec l’un de nos sites mondiaux. Visit our Contact Page to connect with any of our global sites.Visit our Contact Page to connect with any of our global sites. At the forefront of ultrafast laser technology since its introduction, Coherent is now enhancing our long-held commitment to deliver Better Ultrafast, Every Day by spearheading an Industrial Revolution in Ultrafast Science. What’s the effective cost of your experimental data.Applied to our newest generations of. This diagram summarizes the range and also indicates the compatibility of the various available products. For example, the Synchrolock-AP accessory is compatible with the Mira and Vitara, but incompatible with the Chameleon. Similarly, the Pulse Switch is compatible with the Mira-900, but incompatible with the Mira-HP. Please refer to the specifications on the individual product pages and the accessory compatibility charts on page 81 for more details. If. The diagram below summarizes the range available and also indicates the compatibility of the various products. Please note that not all oscillator versions are compatible with all versions of our amplifiers. Please refer to the specifications on the individual product pages for more details. If you still have questions regarding specifications or product compatibility, please. This chip has a thickness of only a few microns and is pumped by a diode laser, to generate an infrared beam at a wavelength determined by the chip properties. In all the Verdi G models, the oscillating wavelength is 1064 nm intracavity doubled to produce a 532 nm green. All models share the same sealed monolithic construction and compact footprint enabling easy integration and. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.

Data on a Virtex-5 FPGA are provided. View on IEEE doi.org Save to Library Create Alert Cite Launch Research Feed Share This Paper Top 2 of 2 Citations View All Radiation Experiments on CMOS PLLs J. Prinzie, M. Steyaert, P. Leroux 2018 Radiation Hardened CMOS Integrated Circuits for Time-Based Signal Processing J. Prinzie, M. Steyaert, P. Leroux 2018 3 Figures and Tables from this paper. The RB300 arm fitted has a non-standard counterweight The Rega Planar 3, together with its successors, the P3 and RP3, is a well-known budget audiophile turntable by British hi-fi manufacturer, Rega Research available since 1977. It was a belt-drive deck that broke from convention, by employing a solid plinth in lieu of the compliantly-suspended chassis or sub-chassis used in many quality turntables since the early 1960s.Rega reports that only 2 part assemblies remain unchanged from the prior RP3 model, the dustcover and dustcover hinges. Significant revisions to plinth, platter, tonearm show net improvements in fit and finish, as well as performance. The new plinth is an MDF core with a high-pressure acrylic laminate finish, and thicker braces, for improved strength and aesthetics, lowering noise floor and improving response. The main bearing well has been completely redesigned to reduce pressure on the ball bearing and hub, while allowing for a higher tolerance assembly, netting smoother operation and lower noise. The 12mm platter is a new glass material, dubbed Optiwhite, is noticeably clearer in appearance and is said to be machined to higher tolerance which improves rotational stability. The 24V AC synchronous motor has a new control PCB and housing cover for greater consistency during assembly and improved reliability, and the power switch has been relocated under the plinth for better ergonomics. New feet are said to lower noise transfer into the turntable, via a new stiffer, wider, hollow cone design constructed from Santoprene rubber.

As always, the Planar 3 is still produced in Rega's UK manufacturing plant located in Southend-on-Sea, Essex UK. Remarkably, the 2016 Planar 3 only rose in price nominally from its predecessor, revealing the benefits of Rega's increased manufacturing capacity and popularity.Archived from the original on 21 November 2013. Archived from the original on 21 November 2013. Archived from the original on 21 November 2013. Archived from the original on 21 November 2013. Archived from the original on 21 November 2013. Archived from the original on 21 November 2013. By using this site, you agree to the Terms of Use and Privacy Policy. Pulses from the RegA amplifier are split into two beams. One beam produces whitelight continuum to seed the parametric amplification process while the other beam pumps the BBO non-linear crystal. Tuning involves a simple manual adjustment of the OPA crystal and a delay line. We have supported our customers throughout Australia and New Zealand for over 30 years with our highly experienced team. If you need an account, please register here View Affiliations The University of Tennessee Space Institute, 411 B.H. Goethert Parkway, Tullahoma, Tennessee 37388, USA We address the issues of light delivery to the photomodification site and show the versatility of the system using tight focusing. Amplified femtosecond pulses are generated by a Ti:sapphire laser oscillator and a chirped-pulse regenerative amplifier, both pumped by a diode-pumped frequency doubled neodymium-doped yttrium orthovanadate ( Nd: YVO 4 ) laser operating at 532 nm. This effective combination could help to shed light on the influence of the local structure fluctuations on controllability of the laser processing and the role of the irradiation in the ablation processes ruling out possible imprecisions coming from the use of the two independent techniques. ACKNOWLEDGMENTS Tom Smith, President of Diamond Edge Co., furnished the synthetic single crystal diamond samples.

The authors acknowledge funding from the Tennessee Higher Education Commission through the Center for Laser Applications at University of Tennessee Space Institute. Mr. Douglas K. Warnberg is acknowledged for valuable technical input. REFERENCES Section: Choose Top of page ABSTRACT I.INTRODUCTION II.MATERIALS AND METHODS III.EXPERIMENTAL RESULTS. IV.SUMMARY REFERENCES CITING ARTICLES 1. Recent Advances In Laser Processing of Materials, edited by J. Perriere, E. Millon, and E. Fogarassy ( Elsevier, New York, 2006). KGaA, Weinheim, 2006)., Google Scholar Crossref 3. Laser Ablation and Its Applications, edited by C. Phipps ( Springer, New York, 2007)., Google Scholar Crossref 4. E. Mazur, Proceedings of the Conference On Lasers and Electro-Optics Europe, Munich, Germany, 2009. Google Scholar Crossref 7. Modern Techniques in Raman Spectroscopy, edited by J. J. Laserna ( Wiley, New York, July 1996). Google Scholar 8. Infrared and Raman Spectroscopy: Methods and Applications, edited by B. Schrader ( VCH, Weinberim, 1995)., Google Scholar Crossref 9. E. Smith and G. Dent, Modern Raman Spectroscopy: A Practical Approach ( Wiley, Chichester, 2005). Google Scholar 10. Raman Spectroscopy for Chemical Analysis, edited by J. D. Winefordner ( Wiley-Interscience, New York, 2000), Vol. 157. Google Scholar 11. G. Turrell and P. Dhamelincourt, in Modern Techniques in Raman Spectroscopy, edited by J. J. Laserna ( Wiley, New York, 1996). Google Scholar 12. R. O. Dillon, J. A. Woollam, and V. Katkanant, Phys. Rev. B 29, 3482 (1984)., Google Scholar Crossref 13. A. C. Ferrari and J. Robertson, Phys. Rev. B 61, 14095 (2000)., Google Scholar Crossref 14.Article views prior to December 2016 are not included. This determination of affiliate status is not necessarily conclusive. The Company integrates these technologies into a wide variety of products and systems designed to meet the productivity and performance needs of customers.

Major markets include the scientific research community; medical institutions, clinics and private practices; and lasers also support commercial applications ranging from semiconductors and disk mastering to light shows and entertainment. Coherent also produces and sells optical and laser components to other laser system manufacturers. The emitted radiation oscillates within an optical resonator and is amplified by an active media, resulting in a monochromatic beam of light which is narrow, highly coherent and thus can be focused to a small spot with a high degree of precision. Lasers are characterized by the active media or materials that produce the energy beams. Since inception in 1966, the Company has grown through a combination of internal expansion, joint ventures and acquisition of companies with related technologies and products. PRODUCTS ELECTRO-OPTICAL Coherent's electro-optical products include lasers and laser systems for scientific, medical research, micromachining, commercial applications, precision optics and related accessories. The principal lasers produced by the Company's Electro-Optical segment are argon and krypton ion, excimer and carbon dioxide (CO(2)), liquid dye, Neodymium:Yttrium-aluminum-garnet (Nd:YAG), Titanium:Sapphire (Ti:Sapphire), and diode-pumped solid state (DPSS). These lasers have a broad range of power and operate in the visible (V), ultraviolet (UV) and infrared (IR) portions of the electromagnetic spectrum. The Company's optics and optical products include special purpose lenses, mirrors and advanced optical coatings. Coherent's electro-optical products are sold for scientific, medical and commercial applications to both end users and original equipment manufacturers (OEMs). SCIENTIFIC GROUP Coherent's Laser Group (CLG) and Lambda Physik, GmbH, the Company's 80% owned subsidiary in Gottingen, Germany, comprise the Scientific Group.

CLG is headquartered in Santa Clara, California and is a leading developer and manufacturer of ion, dye, solid state Nd:YAG, Ti:Sapphire, DPSS and CO(2) lasers for the scientific, OEM and 2 micromachining markets. The lasers sold by CLG are used in basic and applied research in medicine, chemistry, physics, biology, biochemistry, engineering and forensic sciences and in a variety of commercial applications including materials processing, semiconductor microlithography, interferometric wafer inspection, optical disk manufacturing, analytical instrumentation, floptical disk manufacturing and laser light shows. During fiscal 1994, CLG added two new products to its Ultrafast product line. In fiscal 1994, the DPSS 532 product line was expanded to include a 400 milliwatts green version. This laser will expand the applications of DPSS lasers to holography, non-destruction testing, analytical instrumentation and reprographics. Fiscal 1994 marked the entry of Coherent into the high-energy solid-state pulsed Q-Switched laser market. Most initial applications of this laser will be in the scientific field and in materials processing. During the current fiscal year, the Company also solidified its position in the deep ultraviolet (DUV) (257-207 nanometers) market by advancing the technology from milliwatt to multiwatt power levels. Applications include writing gratings on fibers, optical inspection and lithography. Particular attention was also paid to better servicing the needs of the Company's core businesses. This effort resulted in further refinement of products offered in the principal market segments. These markets include optical lithography, microscopy, optical inspection, instrumentation and manufacturing. This technology has now been incorporated into several customer processes in the expanding area of micromachining. Coherent's subsidiary, Lambda Physik, GmbH, develops and manufactures excimer and pulsed dye lasers.

The excimer laser is an efficient means of producing coherent UV light. Initially limited to research applications, the excimer laser is now also used for materials processing applications in the semiconductor industry, other commercial markets and in medical applications. The Lambda 1000 (medium power) and the Lambda 3000 (high power) XeCl lasers are particularly suitable for processing of multichip modules and high density printed circuit boards for mainframe computers. NovaTube together with the new integrated Halogen generator, introduced in 1994, results in a quasi-sealed excimer laser system. The new LITHO excimer laser directed on industrial microlithography applications, reaches a bandwidth below one picometer and an average power of 8 watts. With these specifications, the laser technologically exceeds the performance of all available lithography lasers. The SCANmate 3 OPPO expands the tuning range far into the infrared down to 2.5 microns with the same bandwidth as the original dye laser. In fiscal 1993, Lambda Physik introduced the first commercially manufactured high pulse energy femtosecond (fs) laser system, the LPD 500fs. The LPD 500fs brings even more performance and simplified operation to the Lambda Physik dye laser product line. Lambda Physik's ongoing commitment to dye lasers has produced some of the most respected models in the world: the FL 2002, the FL 3002 and the LPD 3002. The 1993 model, the Lambda SCANmate narrow band pulsed dye laser series, is 60% smaller than its predecessor and features an optional built-in Nd:YAG pump laser. COMPONENTS GROUP Coherent's Auburn Group (CAG) manufactures optics, thin film coatings for high-performance laser optics, laser accessories and electro-optical components for the Company as well as other manufacturers.

Optics and thin film coatings, which consist of mirrors and lenses used for imaging and directing a laser beam, are used in the Company's own laser products, in low-loss coated optics for OEMs and other commercial applications. During fiscal 1994, the Company purchased the business and net assets of Vinten Electro-Optics Ltd. (VEOL), a wholly-owned subsidiary of Vinten Group plc located in Leicester, England which is now operating as Coherent Optics Europe Ltd. (COEL). COEL is the leading supplier of optical components and windows for infra-red imaging systems built in Western Europe. These systems are sold to both military and commercial customers. COEL has become the Company's center for optics manufacturing and sales in Europe. CAG also designs and manufactures laser measurement instruments and accessories that are used to measure and maximize the performance of laser systems. During the current fiscal year, the Company purchased the beam diagnostic product line of Big Sky Laser Technologies, Inc., in Bozeman, Montana. The beam profilers pioneered by Big Sky are complementary to Coherent's beam propagation analyzers. MEDICAL Coherent's Medical Group (CMG) develops, manufactures and distributes a broad line of surgical laser systems used in ophthalmology, gynecology, urology, dermatology, ear, nose and throat (ENT) surgery, orthopedics, general surgery, cosmetic reconstructive, oral maxillofacial, neurology, oncology, otolaryngology, podiatry, medical therapy and other medical specialties. These lasers are designed to improve the quality of patient care, frequently decreasing overall treatment cost compared to conventional procedures. Most of these products also make it possible to perform treatments in a doctor's office, surgery centers or outpatient centers in hospitals instead of requiring inpatient hospitalization.

4 Ophthalmic products: In ophthalmology, a market segment in which Coherent pioneered and is still the leader, CMG offers argon, krypton and dye lasers or combinations of these lasers for photocoagulation and treatment of glaucoma as well as Nd:YAG lasers for photodisruption. Coherent now sells an excimer refractive surgery system in many countries in the world. Coherent's argon photocoagulator was the first such device to achieve widespread acceptance by the medical community for treatment of diabetic retinopathy, retinal detachments and glaucoma. The argon photocoagulator is also used in treatment of age related macular disease. Coherent's Nd:YAG laser photodisruptors are used primarily for posterior capsulotomies. These solid-state, pulsed-wave lasers provide ophthalmologists with a method for treating secondary cataracts in a non-invasive manner. Unlike the argon, krypton and dye lasers used in photocoagulation, Nd:YAG lasers produce high power pulses as short as ten billionths of a second. Nd:YAG lasers are also used for iridotomies, a procedure used in the treatment of closed angle glaucoma, whereby the laser makes a hole in the iris facilitating the outflow of fluid trapped in the eye. This outflow relieves pressure which, if left untreated, could cause damage to the optic nerve. Clinical testing for regulatory approval in the United States and Japan will begin in fiscal 1995. This product uses an argon fluoride laser from Lambda Physik to obtain high energy, excellent reliability and safe operation. With instantaneous switching among red, yellow, and green treatment options, the retinal surgeon can now benefit from the technology improvements which have satisfied the broader photocoagulator market for years. Also in fiscal 1994, clinical trials began on a new erbium laser for the most delicate forms of retinal and vitreal surgery. This product is allowing surgeons to perform techniques that were concepts only a few months ago.

The trials are expanding to ten sites around the world to allow international experts to participate in this surgical advance. The system can be transported to the patient for treatment in convalescent or retirement care facilities, or used in the operating room, as well as in intensive care nurseries for retinopathy of prematurity. In fiscal 1990, Coherent introduced the Novus 2000, its first internally liquid cooled argon photocoagulator. This innovation substantially extends the laser tube life. During fiscal 1991, the Novus product line was expanded with the addition of several accessories and a specially designed and internationally certified export model. A new disposable Acculite endophotocoagulation probe was also introduced for use during vitrectomy surgery. 5 Surgical products: Coherent has developed two groundbreaking families of laser instruments that are changing the way surgery is performed. With delivery devices much smaller than conventional instruments, these systems are expanding the range of procedures that can employ new minimally invasive techniques. Because this high energy laser cleanly vaporizes tissue without scarring, it is preferred by gynecologists for performing delicate infertility procedures. Since its introduction, this laser has been used for over 80,000 arthroscopic procedures. Coherent offers a line of CO(2) lasers for a wide range of surgical specialties and applications. All of these lasers utilize new sealed tube technology which greatly increases tube life over other designs and does not require external gas or water supplies. New applications for lasers in the above referenced specialties are continually under development. The Company's CO(2) lasers offer a range of power from 45 to 100 watts. This system combines the Ho:YAG and the Nd:YAG lasers and is the first system to offer tissue cutting and coagulation and stone management (lithotripsy) in a single package.

The DuoTome fiber delivery systems allow delivery of either the Ho:YAG or the Nd:YAG laser energy through the same fiber. These systems provide much greater flexibility and are finding unique applications in the rapidly growing laser prostatectomy market. UltraPulse lasers represent a true departure in design and performance from conventional CO(2) lasers. This new technology offers significant advantages in terms of laser effect on tissue and surgical precision. The same high-pulse energy that is advantageous for gynecology has clinical advantages for the treatment of a variety of skin conditions, thereby opening market opportunities in cosmetic surgery and dermatology. Coherent's VersaPulse holmium solid state lasers began shipment in late fiscal 1990 and have emerged as the technology of choice for orthopedic surgery. The VersaPulse, which is fiber-optically delivered, is an ideal laser for cutting, ablating and sculpting meniscal and cartilaginous tissue with optimum hemostasis and lack of bleeding. Coherent was issued a U.S. patent on the use of the holmium laser for arthroscopy through fiber delivery devices in a liquid environment. In addition, Coherent holds a number of key patents describing the fiber optic delivery systems used with these lasers. Since 1991, Coherent has expanded the VersaPulse line of lasers with higher-power systems for arthroscopy, and has introduced an extensive range of disposable fiber products for several surgical specialties. In the fall of 1993, a new generation called the VersaPulse Select was introduced. This system doubled the power available to the arthroscopic surgeon while reducing system size to nearly half that of the first generation designs. VersaPulse is approved by the FDA for joint arthroscopy, for open and intra-abdominal procedures in general surgery and for lower back surgery. Additional approvals for soft-tissue urology and functional endoscopic sinus surgery have been granted FDA approval.

During 1994, approvals for gynecology and lithotripsy were added to this expanding list of VersaPulse applications. During this fiscal year, Coherent was the first company granted government approval to market a holmium laser for orthopedics in Japan. 6 The medical laser systems manufactured by Coherent's Medical Group are subject to regulation and control by the Food and Drug Administration and other international regulatory agencies. Coherent's products are sold internationally through direct sales personnel located in the United Kingdom, Germany, France, The Netherlands, Japan (Lambda Physik products for OEM and micromachining only) and Hong Kong, as well as through independent representatives in other parts of the world. The Company's foreign sales are made principally to customers in Europe and Japan, but sales are also made to customers in Canada, Latin America, the Peoples Republic of China, other parts of Asia, Australia, the Middle East and Africa. Sales made to independent representatives and distributors (except for Japanese distribution for the Medical segment) are generally priced in U.S. dollars. Foreign sales made directly by the Company are generally priced in local currencies and are therefore subject to currency exchange fluctuations. Coherent's products are broadly distributed and no one customer accounted for more than 10% of total sales during fiscal 1994. The Company gives various warranties on its products and offers service on a contractual basis after the initial product warranty has expired. Coherent maintains a customer support and field service staff in major markets in the United States, Europe, Hong Kong and Japan. This organization works closely with customers and customer groups in servicing equipment, training customers to use the Company's products and exploring additional applications of the Company's technologies.

PRODUCTION AND SOURCES AND AVAILABILITY OF MATERIALS The Company's production operations consist primarily of assembling and testing its products, although the Company manufactures substantially all of its laser tubes and optics. The Company depends upon outside suppliers for most product components, many of which are manufactured to the Company's specifications. The Company has not experienced any significant difficulty in obtaining raw materials and components in the past. There is always a possibility of periodic, short-term disruption of supplies of critical, high technology components; however, the Company does not believe that such disruptions would have a material adverse impact on the Company's financial position or results of operations. PATENTS AND LICENSES Coherent has a significant number of U.S. and foreign patents for technology incorporated into its products. The Company believes it owns or has the right to use the basic patents covering its products. However, each year there are hundreds of patents granted in the world related to lasers and their applications and from time to time the Company has been notified that it may be infringing patents owned by others. In the past, the Company has been able to obtain patent licenses for patents related to its products on commercially reasonable terms. The failure to obtain a key patent license from a third party could cause the Company to incur liabilities for patent infringement and, in the extreme case, to discontinue manufacturing the products that infringe upon the patent. Management 7 believes that none of the Company's current products infringe upon a valid claim of any patents owned by third parties, where the failure to license the patent would have a material and adverse effect on the Company's financial position or results of operations. Orders used to compute backlog are generally cancelable without substantial penalties.

Historically, the rate of cancellation experienced by the Company has not been significant; however, since orders are cancelable, the backlog of orders at any point in time is not necessarily indicative of future revenues. The Company anticipates filling the present backlog during fiscal 1995. Backlog at October 1, 1994 was higher than at September 25, 1993 in both the Electro- Optical and Medical business segments. COMPETITION The laser industry is fragmented, with numerous companies providing one or more products in each of the Company's business segments. No single competitor is dominant in any of the Company's business segments, principally because of the Company's diversity of products and product applications. The markets in which Coherent is engaged are subject to intense competition and rapid technological change. The principal factors of competition for all products are reliability, price, performance, service, marketing and distribution, technological achievement and human resources. Coherent believes that it competes favorably as to these factors, but that continued emphasis upon development of new and improved products and the continued development of successful channels of distribution will be necessary to maintain or increase the Company's share of the laser markets in which it competes. Several of the Company's present competitors have substantially greater financial and other resources than the Company. RESEARCH AND DEVELOPMENT Coherent maintains separate research and development staffs in both of its major business segments. Development of new and improved electro-optical and medical products is primarily the responsibility of engineering development and applications staffs located in the U.S., Germany and the United Kingdom. Such engineering staffs design and develop both new products and enhancements to existing products.